Lifecore Biomedical, Inc. \De\ (LFCR) Income from Discontinued Operations (2017 - 2024)

Lifecore Biomedical, Inc. \De\'s Income from Discontinued Operations history runs 8 years deep, the most recent figure standing at 3000.0 for Q2 2024.

• In Q2 2024, Income from Discontinued Operations changed N/A year-over-year to 3000.0; the TTM figure through Aug 2024 stood at 24000.0 (up 500.0% YoY), while the FY2024 annual figure was 18000.0, changed N/A from the prior year.
• Income from Discontinued Operations for Q2 2024 stood at 3000.0, down from 3000.0 in the prior quarter.
• The five-year high for Income from Discontinued Operations was 3427000.0 in Q4 2021, with the low at 4342000.0 in Q2 2020.
• The 5-year median for Income from Discontinued Operations is 6000.0 (2023), against an average of 413000.0.
• The sharpest annual moves came in 2020 and 2021: Income from Discontinued Operations slumped 2138.14% in 2020, then jumped 526.24% in 2021.
• Lifecore Biomedical, Inc. \De\'s Income from Discontinued Operations stood at 804000.0 in 2020, then surged by 526.24% to 3427000.0 in 2021, then plunged by 124.72% to 847000.0 in 2022, then surged by 102.83% to 24000.0 in 2023, then sank by 112.5% to 3000.0 in 2024.
• Business Quant data shows LFCR's Income from Discontinued Operations at 3000.0 in Q2 2024, 3000.0 in Q1 2024, and 24000.0 in Q4 2023.